Rigel Pharmaceuticals, Inc. (RIGL) Misses Q2 EPS by 4c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Nasdaq ticks up as tech stocks steady; SpaceX worries hit telecoms
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude jumps to highest since April on Houthi-Saudi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) | Delayed: 48.00 -0.86 (1.76%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $48.86 | 52 Week High | $4.38 | |||
| Open | $48.48 | 52 Week Low | $1.88 | |||
| Day High | $48.48 | P/E | N/A | |||
| Day Low | $47.47 | EPS | $-1.12 | |||
| Volume | 37,589 | |||||
